Wall Street Zen

Company

Last mentioned: 4h ago

Stories mentioning Wall Street Zen 2

pharma Neutral

Wall Street Zen Upgrades Codexis and Enovis on Strong 2026 Growth Outlooks

Wall Street Zen has upgraded the stock ratings for Codexis (CDXS) and Enovis (ENOV), signaling increased confidence in their long-term strategic pivots. The upgrades follow robust quarterly performances and the unveiling of ambitious 2026 revenue targets driven by high-margin technological innovations.

2 sources
pharma Neutral

Organogenesis Upgraded to Buy as Regenerative Medicine Gains Momentum

Wall Street Zen has upgraded Organogenesis (NASDAQ: ORGO) to a 'Buy' rating, signaling increased confidence in the regenerative medicine specialist's market position. This move comes amid a broader wave of optimistic re-ratings for mid-cap growth stocks across multiple sectors, including oilfield services and software.

3 sources